New trial aims to improve pregnancy outcomes with smart glucose monitoring

NCT ID NCT06310356

Recruiting now Disease control Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a continuous glucose monitor (CGM) can improve pregnancy outcomes for women with gestational diabetes compared to standard finger-prick testing. About 386 women from Belgium and Australia will be randomly assigned to use either a CGM or a regular glucometer. The goal is to see if CGM reduces complications like early delivery, large babies, or newborn health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES

Contacts and locations

Locations

AZ Groeninge Kortrijk
RECRUITING

Kortrijk, 8510, Belgium
AZ Oostende
RECRUITING

Ostend, Belgium
AZ St Jan Brugge
RECRUITING

Bruges, 8000, Belgium
AZ St Lucas Gent
RECRUITING

Ghent, Belgium
AZ St Maarten Mechelen
RECRUITING

Mechelen, Belgium
CHU de Liège
RECRUITING

Liège, Belgium
Campbelltown Hospital
RECRUITING

Sydney, CAMPBELLTOWN NSW, 2560, Australia
Erasme
RECRUITING

Brussels, Belgium
Imelda Bonheiden
RECRUITING

Bonheiden, 2820, Belgium
OLV Aalst-Asse
RECRUITING

Aalst, Oost-Vlaanderen, 9300, Belgium
Royal Prince Alfred Hospital
RECRUITING

Sydney, Camperdown NSW, 2050, Australia
UZ Gent
RECRUITING

Ghent, 9000, Belgium
UZ Leuven
RECRUITING

Leuven, Belgium
UZA
RECRUITING

Antwerp, Belgium
Vitaz
RECRUITING

Sint-Niklaas, Belgium
ZNA Antwerpen
RECRUITING

Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.